Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

U.S. Genomics Announces New Chief Executive Officer

Published: Friday, December 16, 2005
Last Updated: Friday, December 16, 2005
Bookmark and Share
John J. Canepa has been promoted to President, CEO and member of the Board of Directors.

U.S. Genomics has announced that John J. Canepa has been promoted to President, Chief Executive Officer and member of the Board of Directors.

"John's business acumen, combined with his extensive experience in the life sciences, represents an unparalleled set of qualifications to lead this company through its commercialization efforts and the next phase of its biodefense contract," said Gus Lawlor, Managing Director at HealthCare Ventures and a U.S. Genomics board member.

"We are excited to move forward in this next phase of biodefense development and commercialization of the single molecule biology technology under John's leadership."

Canepa originally joined U.S. Genomics as Chief Financial Officer. During his tenure as CFO, Canepa saw the Company through the development and launch of the Trilogy® 2020 platform and Direct™ miRNA assays and through two phases of a multi-million-dollar biodefense contract with the U.S. Department of Homeland Security.

Prior to joining U.S. Genomics, Canepa served as Vice President, Finance & Administration, and Chief Financial Officer of Winphoria Networks, Inc., a venture capital-backed telecommunications company.

Previously he was a senior partner in the Boston office of Arthur Andersen, where he led the firm's worldwide life sciences practice.

Canepa holds a Masters in Finance from Michigan State University and a B.A. from Denison University.

"U.S. Genomics has made great strides with its biodefense work and this is an especially exciting time to be part of this company," said Canepa.

"It is a privilege to lead such a dynamic team in both the biodefense applications and the development of the Trilogy 2020 platform and assays."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,400+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

U.S. Genomics Announces Recipient of Outstanding Investigator in Single Molecule Biology Award
Dr. James A. Spudich will be presented the award at the 50th Annual Meeting of the Biophysical Society.
Tuesday, February 21, 2006
NSF Awards U.S. Genomics a $500K Phase II-B SBIR Grant
The $500,000 grant is earmarked for development of a commercial platform that uses the Company's rapid DNA analysis and genomic mapping technologies.
Friday, October 07, 2005
U.S. Genomics Expands its Efforts With New VP
U.S. Genomics Names Duncan Whitney as Vice President of Research and Development.
Friday, September 30, 2005
Scientific News
NASA's DNA Sequencing in Space is a Success
DNA has been sequenced in space for the first time ever for the Biomolecule Sequencer investigation, using the MinION sequencing device.
Molecule Prevents Effect of Chemotherapy
Danish researchers from Aarhus University Hospital and Aarhus University have made a possible breakthrough in the treatment of colorectal cancer.
Tasmanian Devils Evolve To Resist Deadly Cancer
Tasmanian devils are evolving in response to a highly lethal and contagious form of cancer, a Washington State University researcher has found.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Blinding Disease in Canines and Humans Shares Causative Gene, Pathology
Scientists report that they’ve directly compared the disease course between humans and dogs and found remarkable similarities.
Probing How CRISPR-Cas9 Works
New study in Journal of Cell Biology examines DNA targeting dynamics in live cells.
Diagnosing Tumors of Unknown Origin
EPICUP® test is a tool that helps to identify up to 87% of cancers of unknown origin (COD).
Genome Editing Without Cleaving DNA
A team involving Kobe University researchers has succeeded in developing ‘Target-AID’, a genome editing technique that does not cleave the DNA.
New Possibilities Tumor Research
Grazer researchers say gene activity of the tumor from the analysis of circulating DNA in blood ahead.
Controlling Genome Editing with Light
New technique offers precise manipulation of when and where genes are targeted.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!